The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of SSEA-3 expression of human embryonic stem (ES) cells. H9 human ES cells (WiCell, Madison, WI) passage 41 grown in mTESR™1 media (StemCell Technologies) were harvested with Accutase™ (Cat. No. 561527) and stained with BD Horizon™ BV421 Rat Anti-SSEA-3 (solid line) or a BD Horizon™ BV421 rat IgM, κ isotype control (Clone R4-22, Cat. No.562708, dashed line). Flow cytometry was performed on a BD™ LSRII flow cytometry system.
Flow cytometric analysis of SSEA-3 expression of human embryonic stem (ES) cells. H9 human ES cells (WiCell, Madison, WI) passage 41 grown in mTESR™1 media (StemCell Technologies) were harvested with Accutase™ (Cat. No. 561527) and stained with BD Horizon™ BV421 Rat Anti-SSEA-3 (solid line) or a BD Horizon™ BV421 rat IgM, κ isotype control (Clone R4-22, Cat. No.562708, dashed line). Flow cytometry was performed on a BD™ LSRII flow cytometry system.
Flow cytometric analysis of SSEA-3 expression of human embryonic stem (ES) cells. H9 human ES cells (WiCell, Madison, WI) passage 41 grown in mTESR™1 media (StemCell Technologies) were harvested with Accutase™ (Cat. No. 561527) and stained with BD Horizon™ BV421 Rat Anti-SSEA-3 (solid line) or a BD Horizon™ BV421 rat IgM, κ isotype control (Clone R4-22, Cat. No.562708, dashed line). Flow cytometry was performed on a BD™ LSRII flow cytometry system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The MC-631 monoclonal antibody reacts with Stage-Specific Embryonic Antigen-3 (SSEA-3), a carbohydrate epitope on the major ganglioside, but not the neutral glycolipid, of mouse embryos and human teratocarcinoma cells. As its name implies, the expression of SSEA-3 is stage-specific and can be used to characterize embryonic cells and monitor their differentiation. However, its expression pattern differs between human and mouse. In the human, SSEA-3 is found on teratocarcinoma (embryonal carcinoma or EC), embryonic inner cell mass (ICM), embryonic stem (ES) cells, and erythrocytes. As human stem cells undergo differentiation, SSEA-3 expression diminishes. In the mouse, SSEA-3 is found on oocytes, ova, zygotes, early cleavage-stage embryos, early blastocysts, ICM, primitive endoderm, and adult kidneys, but not on EC or ES cells.
The antibody was conjugated to BD Horizon™ BV421 which is part of the BD Horizon™ Brilliant Violet™ family of dyes. With an Ex Max of 407-nm and Em Max at 421-nm, BD Horizon™ BV421 can be excited by the violet laser and detected in the standard Pacific Blue™ filter set (eg, 450/50-nm filter). BD Horizon™ BV421 conjugates are very bright, often exhibiting a 10 fold improvement in brightness compared to Pacific Blue™ conjugates.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.